الفهرس | Only 14 pages are availabe for public view |
Abstract Trigger finger (Stenosing Tenosynovitis) is a commonly encountered condition in daily orthopedic practice. Several causes of trigger finger have been proposed, though the precise etiology has not been elucidated The initial complaint with trigger finger maybe of a painless clicking with digital manipulation. Further development of the condition can cause the catching or popping to become painful with both flexion and extension, and be related as occurring at either the metacarpophalangeal or pip joints. The classic presentation of popping and locking of a trigger finger is typically all that is needed for diagnosis, however with acute onset of symptoms patients may present with pain and swelling over the involved flexor sheath with avoidance of finger motion .In these case the classic popping and triggering are not seen and the diagnosis of trigger must be differentiated from infection or some other traumatic injury. Initial management of trigger finger is conservative and involves activity modification, NSAIDS, drugs for pain control, MCP joint immobilization and corticosteroid injection. Injection of corticosteroids for the treatment of trigger finger should be attempted before surgical intervention especially in patients with recent onset of symptoms and one affected digit with palpable nodule. Indications for surgical treatment are generally failure of conservative treatment to resolve pain and symptoms. The timing of surgery is somewhat controversial. Operative treatment whether by percutaneous or open release is highly successful and widely regarded as the ultimate treatment for trigger finger. This study included thirty patients with a total of thirty seven trigger fingers with persistent symptoms after at least one previous corticosteroid injection. They were studied to evaluate the results of percutaneous release of trigger finger. The youngest patient was 33 years and the oldest was 70 years with a mean of 51.53 ± 10.673 years. There were 26 females and 4 male in the study, the female: male ratio was 6.5:1. The duration of symptoms averages from 6 months up to 36 months. The thumb was affected 16 times (41%), the middle finger 10 times (25.6%), the ring finger 9 times (23%), the index finger 4 times (10.2%) and the little finger was not affected in any patient. There was multiple finger affection in 7 patients (23.3%) and only one finger affected in 23 patients (76.7%). There were 19 patients without history of systemic diseases (63.3%) and 11 patients with history of diabetes mellitus (36.7%) in the study. All patients were treated by percutaneous release of trigger finger done under local anesthesia with the palm and affected finger are prepared with antiseptic solution. After the release an adhesive bandage is applied and the patients are instructed to use the hand for activities as tolerated and they are able to remove the dressing themselves the next day. The patients were followed up for a period of three months. The overall results at the end of the study were excellent in 26 patients (86.7%), good in 3 patients (10%) and poor in 1 patients (3.3%). So the results were satisfactory in 29 patients (96.7%) and unsatisfactory in 1 patients (3.3%). At the end of the study, percutaneous trigger finger release is safe ,cost effective method with low complication rate. |